UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $3.23M invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
2
Closed
Calls
$435K
Puts
Net Calls
+$435K
Net Calls Change
+$439K
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
1
Jane Street
New York
$1.85M +$1.85M +56,492 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1.11M +$1.11M +33,955 New
TRCT
3
Tower Research Capital (TRC)
New York
$166K -$289K -8,839 -64%
CG
4
Cutler Group
California
$49K +$49K +1,521 New
Morgan Stanley
5
Morgan Stanley
New York
$26K
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$24K
UBS Group
7
UBS Group
Switzerland
$2K -$255 -7 -11%